In addition, Sheng et al [15] showed that inhibition of CRT decreased the chemoresistance of pancreatic cancer, and previous studies demonstrated that CRT regulates the ERK/MAPK [20], NF-κB [21] and STAT3 [22] pathways. The gene discussed is CALR; the disease is familial pancreatic carcinoma.